Trials / Completed
CompletedNCT02356289
Single Ascending Dose Study of MYK-461 in Healthy Volunteers
Safety, Tolerability, Preliminary Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of MYK-461 in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- MyoKardia, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to establish initial safety, tolerability, pharmacokinetics and pharmacodynamics of MYK-461 in human subjects. This is a randomized, double-blind, placebo-controlled, sequential group, single ascending (oral) dose study in healthy volunteers aged 18-55 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | |
| DRUG | MYK-461 |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2015-07-01
- Completion
- 2015-07-01
- First posted
- 2015-02-05
- Last updated
- 2015-09-23
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02356289. Inclusion in this directory is not an endorsement.